Argentina Joins Peru, Morocco in Approving Chinese COVID-19 Vaccine Trial

World

August 22nd, 10:18am

Asharq Al-Awsat

FILE PHOTO: Small bottles labeled with a "Vaccine COVID-19" sticker and a medical syringe are seen in this illustration taken taken April 10, 2020. REUTERS/Dado Ruvic

Argentina joined Peru and Morocco in approving Phase 3 clinical trials for a coronavirus vaccine developed by China National Biotec Group (CNBG), the company said late Friday. As China forges ahead in the global race to develop a vaccine to curb the COVID-19 pandemic and as cases within China dwindle, CNBG needs research participants from other countries for testing. CNBG will partner with Argentina's ELEA in the vaccine trial, the Chinese company said in a statement late Friday. The experimental vaccine by CNBG, a unit of state-owned pharmaceutical giant China National Pharmaceutical Group (Sinopharm), received approval from the UAE in June for a Phase 3 trial and has since recruited 15,000 volunteers. The company said on Thursday that Peru and Morocco also approved the trials, Reuters reported. CNBG has also obtained approval from Bahrain for a Phase 3 study designed to involve around 6,000 participants.

from Asharq AL-awsat https://english.aawsat.com/home/article/2462846/argentina-joins-peru-morocco-approving-chinese-covid-19-vaccine-trial